Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial
Francesco Zulian(University of Padua), Giorgio Perilongo(University of Padua), Rosa Anna Podda(Boston Children's Hospital), Cristina Vallongo(University of Padua), Giorgia Martini(University of Padua), Anna Belloni Fortina(University of Padua), Francesco La Torre(Ospedale Vito Fazzi), Annalisa Patrizi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Maria Alessio(University of Naples Federico II), Silvana Martino(University of Turin), Fernanda Falcini(University of Florence), Fabio Vittadello, V. Gerloni(Istituto Ortopedico Gaetano Pini), Mauro Paradisi(Istituti di Ricovero e Cura a Carattere Scientifico), Mario Cutrone(Boston Children's Hospital)
Cited by 216
Related Papers
Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients
|Journal of the European Academy of Dermatology and Venereology|2020|248